Water → 6-Bromo-1-[(4-nitrophenyl)sulfonyl]-1H-benzimidazole
Reaction equation
[Br:1][C:2]1[CH:10]=[CH:9][C:5]2[NH:6][CH:7]=[N:8][C:4]=2[CH:3]=1.[H-].[Na+].[N+:13]([C:16]1[CH:21]=[CH:20][C:19]([S:22](Cl)(=[O:24])=[O:23])=[CH:18][CH:17]=1)([O-:15])=[O:14].O>CN(C=O)C.C(Cl)Cl.CO.C(OCC)(=O)C>[Br:1][C:2]1[CH:10]=[CH:9][C:5]2[N:6]=[CH:7][N:8]([S:22]([C:19]3[CH:18]=[CH:17][C:16]([N+:13]([O-:15])=[O:14])=[CH:21][CH:20]=3)(=[O:23])=[O:24])[C:4]=2[CH:3]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 4
Procedure
5-Bromo-1H-benzimidazole (756 mg) was dissolved in anhydrous DMF (3 ml) and cooled in an ice bath. Sodium hydride (60% in mineral oil) (153 mg) was added in one portion. The reaction was stirred for 1 h, before addition of 4-nitrobenzenesulfonyl chloride (850 mg) in DMF (2 ml) to the reaction. The reaction was stirred for a further hour before warming to RT and addition of water (10 ml). The reaction was stirred vigorously then left at RT overnight. Ethyl acetate (ca. 10 ml) was added to the reaction mixture and was then vigorously stirred. The reaction was dissolved in DCM:methanol and passed through a 1 g SAX cartridge. The residue was purified on silica cartridge using cyclohexane:ethyl acetate with a 50-100% gradient. Fractions containing the product were combined and evaporated to dryness to afford the title compound, 401 mg.
Workup
- temperaturecooled in an ice bath
- stirringThe reaction was stirred vigorously
- stirringwas then vigorously stirred
- customThe residue was purified on silica cartridge
- additionFractions containing the product
- customevaporated to dryness
Sources & evidence
- ORD record
- ord-a790b5d1add349c591519a28b8ccaa7c
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09326987B2
Reaction notes
Loading…